AGILE THERAPEUTICS INC - FORM 10-K - EX-23.1 - March 15, 2017

Attached files

file filename
EX-32.2 - EX-32.2 - AGILE THERAPEUTICS INCa2231308zex-32_2.htm
EX-32.1 - EX-32.1 - AGILE THERAPEUTICS INCa2231308zex-32_1.htm
EX-31.2 - EX-31.2 - AGILE THERAPEUTICS INCa2231308zex-31_2.htm
EX-31.1 - EX-31.1 - AGILE THERAPEUTICS INCa2231308zex-31_1.htm
10-K - 10-K - AGILE THERAPEUTICS INCa2231308z10-k.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

        We consent to the incorporation by reference in the Registration Statements:

    (1)
    Registration Statement (Form S-8 No. 333-199441), pertaining to the Agile Therapeutics, Inc. 2014 Incentive Compensation Plan,

    (2)
    Registration Statement (Form S-3 No. 333-205120) of Agile Therapeutics, Inc. and

    (3)
    Registration Statement (Form S-8 No. 333-205116), pertaining to the Agile Therapeutics, Inc. 2014 Incentive Compensation Plan,

of our report dated March 15, 2017 with respect to the financial statements of Agile Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2016.

/s/ Ernst & Young LLP

Metro Park, New Jersey
March 15, 2017



QuickLinks

Consent of Independent Registered Public Accounting Firm

AGILE THERAPEUTICS INC Reports